Corriente Advisors, LLC
- SEC CIK
- 0001406718
- Latest filing
- Feb 14, 2024
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 18, 2021. Long positions only.
- Positions
- 10
- No 13F data for Q4 2020
- Portfolio value
- $271.6M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MAXRMaxar Technologies Inc. | COM | 2,650,000 | $100.2M | 36.9% | – | – | History |
| REPLReplimune Group, Inc. | COM | 1,075,000 | $32.8M | 12.1% | – | – | History |
| CUECue Biopharma, Inc. | COM | 2,549,031 | $31.1M | 11.5% | – | – | History |
| CRDFCardiff Oncology, Inc. | COM | 2,785,410 | $25.8M | 9.5% | – | – | History |
| TDYTeledyne Technologies Inc | COM | 55,000 | $22.8M | 8.4% | – | – | History |
| TFFPTFF Pharmaceuticals, Inc. | COM | 1,565,682 | $21.2M | 7.8% | – | – | History |
| METAMeta Platforms, Inc. | Stock | 50,000 | $14.7M | 5.4% | – | – | History |
| LTRNLantern Pharma Inc. | COM | 713,806 | $12.9M | 4.8% | – | – | History |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 870,228 | $7.96M | 2.9% | – | – | History |
| EYPTEyePoint, Inc. | COM NEW | 200,000 | $2.03M | 0.7% | – | – | History |